col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


59 Results       Page 1

 [1] 
Elsevier: Molecular Therapy
  original article Date Title Authors   All Authors
1 [GO] 2024―May―07 Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immune responses in mice. Nicholas You Zhi Cheang, Kai Sen Tan, Peck Szee Tan, Kiren Purushotorma, Wee Chee Yap, Kirsteen Mcinnes Tullett, et al. (+12)
2 [GO] 2024―Apr―11 mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies Brian Montoya, Carolina R. Melo-Silva, Lingjuan Tang, Samita Kafle, Peter Lidskiy, Csaba Bajusz, et al. (+16)
3 [GO] 2024―Apr―02 Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, Akimasa Hayashi, Theofilus A. Tockary, Yuki Mochida, et al. (+4)
4 [GO] 2024―Mar―25 In vitro and in vivo validation of the antiviral effect of hCypA against SARS-CoV-2 via binding to the RBD of spike protein Woo-Ri Shin, Do-Young Kim, Sang Yong Kim, Gna Ahn, Dae-Young Park, Jiho Min, et al. (+2)
5 [GO] 2024―Feb―09 A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections Namei Wu, Jiachen Zhang, Yanqiong Shen, Xinghai Zhang, Jinge Zhou, Yan Wu, et al. (+5)
6 [GO] 2024―Jan―24 Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2 Kathrin Göritzer, Elisabetta Groppelli, Clemens Grünwald-Gruber, Rudolf Figl, Fengfeng Ni, Huimin Hu, et al. (+8)
7 [GO] 2024―Jan―21 Novel engineered recombinant ACE2 reduces SARS-CoV-2-induced COVID-19 without cardiotoxic side effects Federico Ávila-Moreno
8 [GO] 2024―Jan―11 Distinct roles of vaccine induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease Jingyi Yan, Chandrashekar Ravenna Bangalore, Negin Nikouyan, Sofia Appelberg, Daniela Nacimento Silva, Haidong Yao, et al. (+20)
9 [GO] 2023―Nov―16 A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion Han Feng, Linpu Yang, Hang Yang, Dongwan Cheng, Min Li, Eli Song, Tao Xu
10 [GO] 2023―Nov―04 Intracellular delivery of nuclear localization sequence peptide mitigates COVID-19 by inhibiting nuclear transport of inflammation associated transcription factors Seokwon Lee, Sang-Sun Yoon, Minhee Jo, Mingu Kang, Seungwoo Lee, Young-Jin Seo, et al. (+3)
11 [GO] 2023―Sep―09 Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants Cheng-Pu Sun, Chi-Wen Chiu, Ping-Yi Wu, Szu-I Tsung, I-Jung Lee, Chih-Wei Hu, et al. (+25)
12 [GO] 2023―Aug―30 Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract Sébastien Viollet, Elise Enouf, Justine Picot, Léna Noël, Simon Huet, Déborah Le Pennec, et al. (+4)
13 [GO] 2023―May―26 A non-transmissible live attenuated SARS-CoV-2 vaccine Julia M. Adler, Ricardo Martin Vidal, Anne Voß, Sandra Kunder, Mariana Nascimento, Azza Abdelgawad, et al. (+6)
14 [GO] 2023―May―03 Extracellular vesicles: A promising therapy against SARS-CoV-2 infection Yan Leyfman, Greta Gohring, Muskan Joshi, Gayathri Pramil Menon, Alexandra Van de Kieft, Tania del Rivero, et al. (+2)
15 [GO] 2023―Mar―21 Pseudoknot-targeting Cas13b combats SARS-CoV-2 infection by suppressing viral replication Daseuli Yu, Hee-Jeong Han, Jeonghye Yu, Jihye Kim, Gun-Hee Lee, Ju-Hee Yang, et al. (+5)
16 [GO] 2023―Jan―10 Mechanisms and treatment of COVID-19-associated acute kidney injury Weibin Zhou, John Cijiang He
17 [GO] 2022―Dec―27 A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19 Luigi Aurisicchio, Nadia Brambilla, Marina E. Cazzaniga, Paolo Bonfanti, Stefano Milleri, Paolo A. Ascierto, et al. (+21)
18 [GO] 2022―Dec―15 SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation Hong Cai, Ya Chen, Ye Feng, Morad Asadi, Lewis Kaufman, Kyung Lee, et al. (+9)
19 [GO] 2022―Dec―12 Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest Wenjing Wu, Wenbiao Wang, Liying Liang, Junzhe Chen, Biao Wei, Xiao-Ru Huang, et al. (+3)
20 [GO] 2022―Sep―15 Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery Ferdinando M. Milazzo, Antonio Chaves-Sanjuan, Olga Minenkova, Daniela Santapaola, Anna M. Anastasi, Gianfranco Battistuzzi, et al. (+16)
21 [GO] 2022―Sep―10 The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs Masaud Shah, Hyun Goo Woo
22 [GO] 2022―Aug―10 Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2 Matthew D.J. Dicks, Louisa M. Rose, Rebecca A. Russell, Lesley A.H. Bowman, Carl Graham, Jose M. Jimenez-Guardeño, et al. (+5)
23 [GO] 2022―Jul―31 Moving targets: COVID-19 vaccine efficacy against Omicron subvariants Maria Karolaynne da Silva, Umberto Laino Fulco, Edilson Dantas da Silva Júnior, Jonas Ivan Nobre Oliveira
24 [GO] 2022―May―07 Identification of FDA-approved Bifonazole as SARS-CoV-2 blocking agent following a bioreporter drug screen Zaid Taha, Rozanne Arulanandam, Glib Maznyi, Elena Godbout, Madalina E. Carter-Timofte, Naziia Kurmasheva, et al. (+27)
25 [GO] 2022―Apr―27 An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa Benjamin Vesin, Jodie Lopez, Amandine Noirat, Pierre Authié, Ingrid Fert, Fabien Le Chevalier, et al. (+13)
26 [GO] 2022―Apr―21 A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell mediated immunity Sean McCafferty, AKM Ashiqul Haque, Aster Vandierendonck, Brian Weidensee, Magalie Plovyt, Magdalena Stuchlíková, et al. (+11)
27 [GO] 2022―Mar―24 Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single cell transcriptomics Emanuel Wyler, Julia M. Adler, Kathrin Eschke, Gustavo Teixeira Alves, Stefan Peidli, Fabian Pott, et al. (+19)
28 [GO] 2022―Mar―17 Emerging infections and pandemics: The critical importance of global health equity action Nadia A. Sam-Agudu, Chandy C. John
29 [GO] 2022―Feb―19 COVID-19 mRNA vaccines: platforms and current developments Gábor Tamás Szabó, Azita Josefine Mahiny, Irena Vlatkovic
30 [GO] 2022―Feb―14 The Battle between Host and SARS-CoV-2: Innate Immunity and Viral Evasion Strategies Shilei Zhang, Lulan Wang, Genhong Cheng
31 [GO] 2022―Feb―12 Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy Olga Minenkova, Daniela Santapaola, Ferdinando Maria Milazzo, Anna Maria Anastasi, Gianfranco Battistuzzi, Caterina Chiapparino, et al. (+15)
32 [GO] 2022―Feb―10 Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform Chevillard C, Amen A, Besson S, Hannani D, Bally I, Dettling V, et al. (+10)
33 [GO] 2022―Feb―03 Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2 Vijayakumar Jawalagatti, Kirthika Perumalraja, Chamith Hewawaduge, Myeon Sik Yang, Ji-Young Park, Byung Kwan Oh, John Hwa Lee
34 [GO] 2022―Jan―31 Adenovirus-based vaccines - a platform for pandemic preparedness against emerging viral pathogens Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
35 [GO] 2022―Jan―14 Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV-RNAi expression vectors Jonas Becker, Megan Lynn Stanifer, Sarah Rebecca Leist, Bettina Stolp, Olena Maiakovska, Ande West, et al. (+9)
36 [GO] 2022―Jan―07 Non-invasive administration of AAV to target lung parenchymal cells and develop SARS-CoV-2-susceptible mice Myeon-Sik Yang, Min-Jung Park, Junhyeong Lee, Byungkwan Oh, Kyung Won Kang, Yeonhwa Kim, et al. (+10)
37 [GO] 2022―Jan―03 A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck, Tiffany Chen, Giuseppe Lofano, Kristian Friedrich, et al. (+30)
38 [GO] 2021―Nov―11 Debulking SARS-COV-2 in saliva using angiotensin converting enzyme 2 in the chewing gum to decrease oral virus transmission and infection Henry Daniell, Smruti K. Nair, Nardana Esmaeili, Geetanjali Wakade, Naila Shahid, Prem Kumar Ganesan, et al. (+20)
39 [GO] 2021―Oct―22 Single dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection Stephen Boulton, Joanna Poutou, Nikolas T. Martin, Taha Azad, Ragunath Singaravelu, Mathieu J.F. Crupi, et al. (+26)
40 [GO] 2021―Oct―22 The neutralization effect of Montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies Serdar Durdagi, Timucin Avsar, Muge Didem Orhan, Muge Serhatli, Bertan Koray Balcioglu, Hasan Umit Ozturk, et al. (+20)
41 [GO] 2021―Oct―02 The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant Changjing Cai, Yihan Liu, Shan Zeng, Hong Shen, Ying Han
42 [GO] 2021―Sep―20 COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 Antonella Conforti, Emanuele Marra, Fabio Palombo, Giuseppe Roscilli, Micol Ravà, Valeria Fumagalli, et al. (+49)
43 [GO] 2021―Aug―06 A comprehensive analysis of the efficacy and safety of COVID-19 vaccines Changjing Cai, Yinghui Peng, Edward Shen, Qiaoqiao Huang, Yihong Chen, Ping Liu, et al. (+9)
44 [GO] 2021―May―20 Low-dose single-shot COVID-19 mRNA vaccines lie ahead Niek N. Sanders
45 [GO] 2021―May―14 A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19 Adi Idris, Alicia Davis, Aroon Supramaniam, Dhruba Acharya, Gabrielle Kelly, Yaman Tayyar, et al. (+9)
46 [GO] 2021―May―11 Plant-derived Exosomal MicroRNAs Inhibit Lung Inflammation Induced by Exosomes SARS-CoV-2 Nsp12 Yun Teng, Fangyi Xu, Xiangcheng Zhang, Jingyao Mu, Mohammed Sayed, Xin Hu, et al. (+17)
47 [GO] 2021―Apr―23 Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 Stefania Capone, Angelo Raggioli, Michela Gentile, Simone Battella, Armin Lahm, Andrea Sommella, et al. (+22)
48 [GO] 2021―Apr―05 A Single Dose of Self-Transcribing and Replicating RNA Based SARS-CoV-2 Vaccine Produces Protective Adaptive Immunity In Mice. Ruklanthi de Alwis, Esther S. Gan, Shiwei Chen, Yan Shan Leong, Hwee Cheng Tan, Summer L. Zhang, et al. (+26)
49 [GO] 2021―Feb―10 Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 Spike for viral entry Taha Azad, Ragunath Singaravelu, Zaid Taha, Taylor R. Jamieson, Stephen Boulton, Mathieu J.F. Crupi, et al. (+18)
50 [GO] 2021―Feb―10 Vaccine technologies jockey for primacy in pandemic response Elie Dolgin
51 [GO] 2021―Feb―06 Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines S. Moein Moghimi
52 [GO] 2020―Dec―16 Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 Tesia Bobrowski, Lu Chen, Richard T. Eastman, Zina Itkin, Paul Shinn, Catherine Z. Chen, et al. (+7)
53 [GO] 2020―Oct―13 Prepandemic Preparedness under the Spotlight at ASGCT’s COVID-19 Symposium Elie Dolgin
54 [GO] 2020―Oct―09 The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity Kevin V. Morris
55 [GO] 2020―Oct―09 Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines Eric J. Kremer
56 [GO] 2020―Oct―08 COVID-19-induced ARDS is associated with decreased frequency of activated memory/effector T cells expressing tissue migration molecule CD11a++ Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez-Navarro, Adrian Doevelaar, Felix S. Seibert, Bodo Hölzer, et al. (+25)
57 [GO] 2020―Jun―23 Preparing for Pandemics: RNA Vaccines at the Forefront Jesse H. Erasmus, Deborah Heydenburg Fuller
58 [GO] 2020―Jun―12 The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2 Kevin V. Morris
59 [GO] 2020―Jun―10 Are genetic vaccines the right weapon against Covid-19? Antonella Conforti, Emanuele Marra, Giuseppe Roscilli, Fabio Palombo, Gennaro Ciliberto, Luigi Aurisicchio
 [1] 

59 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec